The invention provides a herpes simplex virus vector comprising deletions in ICP4, ICP27, and UL55.

 
Web www.patentalert.com

< Immunogenic glycopeptides, screening, preparation and uses

> Mutant forms of cholera holotoxin as an adjuvant

> Chimeric alphavirus replicon particles
~ 00518